
Ozempic to cost much less for cash customers
The maker of Ozempic is slashing prices for U.S. patients who pay cash, a major shift in the fast-growing market for diabetes and weight-loss drugs. Novo Nordisk says it will charge $499 a month for the three-dose size of the diabetes treatment. Where customers can get this new price The offer is aimed at patients […]









